Press Releases

​NeoLumina Bioscience In-Licenses Clinical-stage Psilocybin Product Candidate from Filament Health for Eating DisordersPEX010 expands NeoLumina’s psychedelic product pipeline. Funding activity in process to advance clinical development. VANCOUVER, BRITISH COLUMBIA,...

NeoLumina Bioscience Advancing Development of Proprietary Psychedelic-based Therapeutic MedicinesFunding activity initiated to advance lead psilocybin-based product candidate into human studies VANCOUVER, BC (August 30, 2023) – NeoLumina Bioscience Inc. (“NeoLumina”...